Novavax, Inc.

NVAX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$268,023$253,744$263,338$530,230
Short-Term Investments$494,871$358,560$468,141$392,888
Receivables$34,174$226,396$44,510$108,285
Inventory$13,511$10,240$10,263$8,749
Other Curr. Assets$164,011$70,572$81,776$32,514
Total Curr. Assets$974,590$919,512$868,028$1,128,942
Property Plant & Equip (Net)$72,993$282,687$291,033$299,998
Goodwill$113,080$112,958$112,027$107,478
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$19,226$21,392$21,904$24,000
Total NC Assets$205,299$417,037$424,964$431,476
Other Assets$0$0$0$0
Total Assets$1,179,889$1,336,549$1,292,992$1,560,418
Liabilities
Payables$15,227$50,595$34,162$41,579
Short-Term Debt$5,036$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$104,251$113,763$108,334$675,067
Other Curr. Liab.$305,355$132,531$142,031$279,946
Total Curr. Liab.$429,869$389,138$422,170$1,154,416
LT Debt$246,104$170,568$170,126$169,684
Deferred Rev, NC$0$399,263$409,557$446,819
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$660,588$287,585$313,727$359,614
Total NC Liab.$906,692$909,786$946,465$1,029,843
Other Liabilities$0$0$0$0
Cap. Leases$7,305$57,922$58,533$60,735
Total Liabilities$1,336,561$1,298,924$1,368,635$2,184,259
Equity
Pref Stock$0$0$0$0
Common Stock$1,648$1,645$1,642$1,619
Retained Earnings-$4,585,675-$4,383,296-$4,489,804-$5,008,450
AOCI-$1,745-$458$1,608-$22,559
Other Equity$4,429,100$0$0$0
Total Equity-$156,672$37,625-$75,643-$623,841
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,179,889$1,336,549$1,292,992$1,560,418
Net Debt-$16,883-$83,176-$93,212-$360,546
Novavax, Inc. (NVAX) Financial Statements & Key Stats | AlphaPilot